Press Release / Industry / Results of Omkar Speciality Chemicals Ltd for Q4 & FY15

Results of Omkar Speciality Chemicals Ltd for Q4 & FY15

Mumbai, May 19, 2015: Omkar Speciality Chemicals Ltd (OSCL), a leading company in the field of Speciality Chemicals and Active Pharmaceutical Ingredients (APIs), today declared its financial results for the fourth quarter and full year ended March 31, 2015.

The company reported a healthy increase of 63.25% in its Net Profit to Rs. 5.42 crore for Q4FY15, as compared to Rs. 3.32 crore in the corresponding quarter of last fiscal. The companys PAT margin improved from 4.49% in Q4FY14 to 7.34% in Q4FY15.

Total Income for the quarter ended March 31, 2015 stood at Rs. 73.89 crore, as compared to Rs. 73.94 crore in the same period last year.

OSCLs Earnings before Interest, Tax, Depreciation and Amortization (EBITDA) in Q4FY15 stood at Rs. 14.04 crore, up 21.45%. The companys EBITDA margin improved from 15.63% in Q4FY14 to 19.00% in Q4FY15.

For the full year period ended March 31, 2015, OSCLs net profit jumped by 79.06% to Rs. 24.28 crore, as compared to Rs. 13.56 crore of the year ago period. The companys PAT margin improved from 5.64% in FY14 to 9.16% in FY15.

Total income for FY15 stood at Rs. 265.13 crore, recording a rise of 10.34% as compared to Rs. 240.28 crore during FY14. OSCLs EBITDA in FY15 stood at Rs. 52.17 crore, up 21.50%. The companys EBITDA margin improved from 17.87% in FY14 to 19.68% in FY15.

Commenting on the financial performance of the company Mr. Omkar Herlekar, the Whole Time Director, Omkar Speciality Chemicals Ltd, said, The margins have improved considerably as the company is focusing more on speciality chemicals and APIs as compared to commodity chemicals. The margins enjoyed in the former two segments are significantly higher. In the forthcoming fiscal year, the margins are likely to improve further because of higher composition of speciality chemicals and APIs in the total sales.

Earnings per share (EPS) for the quarter ended Q4FY15 stood at Rs. 2.64, up 63.98% as compared with Rs. 1.61 for the quarter ended March 31, 2014. For FY15, EPS stood at Rs. 12.03, up 88.26%, as against Rs. 6.39 in FY14.

The Board of Directors has recommended a dividend of 15% per equity share of Rs. 10 each for FY15.

About Omkar Speciality Chemicals Limited (www.omkarchemicals.com; BSE: 533317; NSE: OMKARCHEM)
A leading speciality chemicals company, OSCLs core business is manufacturing of niche lifesaving intermediates, Active Pharmaceuticals Ingredients (APIs) and Veterinary Growth enhancers. Headquartered at Thane, OSCL has nine units in the state of Maharashtra, India with over 1,100 workforce. The company is fully backward integrated and has an installed capacity of 4,920 MTPA. The Companys product segments include Iodine Compounds, Selenium Compounds, Intermediates, Resolving Agents, Veterinary Growth Enhancers and APIs which comprises of more than 200 products. The Inorganic Intermediates include Selenium derivatives and Iodine derivatives. These products find applications in various industries like Pharmaceutical Industry, Chemical Industry, Glass Industry, Cosmetics, Ceramic Pigments and Cattle & Poultry Feeds. The companys association with leading organizations in India and abroad has enabled it to broaden its business, to expand the existing product range and to develop new molecules as per the specific requirements of customers. The company is certified with ISO 9001:2008 and FAMI-QS & GMP